Peptide COAs

Tirzepatide

70 public audits matching your filters. Scores are PeptIQ’s legitimacy model; missing panels lower thoroughness but aren’t automatically “bad” — open a report to see pass, fail, reported, and missing panels clearly.

Public certificates

Approved community and directory-linked COAs only.

  • Double Agonist + Tirzepatide

    Padre Research · Sep 5, 2026 · Core panels 67% · 3/7 panels · 99.9% purity

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns92Doc score
  • Tirzepatide + Tirzepatide 60mg

    American Peptides · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.9% purity · Doc 92

    Document structure and test panels align with what we expect from authentic lab reports.

    Consistent with a legitimate COA80Solid
  • Tirzepatide + Tirzepatide 20mg

    American Peptides · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.9% purity · Doc 92

    Document structure and test panels align with what we expect from authentic lab reports.

    Consistent with a legitimate COA80Solid
  • Tirzepatide + Tirzepatide 10mg

    American Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.8% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns80Solid
  • Tirzepatide + Tirzepatide 10mg

    American Peptides · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.9% purity · Doc 92

    Document structure and test panels align with what we expect from authentic lab reports.

    Consistent with a legitimate COA80Solid
  • Double Agonist + Tirzepatide

    Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.92% purity · Doc 95

    Document structure and test panels align with what we expect from authentic lab reports.

    Consistent with a legitimate COA79Solid
  • Tirzepatide + GLP TZ

    Simple Peptide · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.96% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns78Solid
  • Tirzepatide + GLP TZ

    Simple Peptide · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.929% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns78Solid
  • Tirzepatide

    American Peptide Research · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.35% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • Tirzepatide

    American Peptide Research · Sep 5, 2026 · Core panels 67% · 2/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • Tirzepatide

    American Peptide Research · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.35% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • Tirzepatide + Tirzepatide 30mg

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.95% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Tirzepatide + GLP TZ

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.617% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Tirzepatide + Tirzepatide 10mg

    Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.58% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Tirzepatide + Tirzepatide 10mg

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.88% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Tirzepatide + GLP TZ

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.784% purity · Doc 15

    Multiple signals on this document conflict with known lab formats or verification patterns.

    Evidence suggests fabrication76Solid
  • Tirzepatide

    Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.89% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Tirzepatide

    Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.98% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Tirzepatide

    Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.957% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Tirzepatide

    Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.91% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Tirz 10mg + Tirzepatide

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 45

    Missing panels or key metadata — not enough evidence to treat this as a full certificate.

    Incomplete documentation76Solid
  • Tirz 10mg + GLP TZ + Tirzepatide

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.714% purity · Doc 62

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.345% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 65

    Missing panels or key metadata — not enough evidence to treat this as a full certificate.

    Incomplete documentation73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.552% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 45

    Missing panels or key metadata — not enough evidence to treat this as a full certificate.

    Incomplete documentation73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.873% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 0% · 1/7 panels · Doc 45

    Missing panels or key metadata — not enough evidence to treat this as a full certificate.

    Incomplete documentation73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 45

    Missing panels or key metadata — not enough evidence to treat this as a full certificate.

    Incomplete documentation73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.414% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Tirzepatide

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.7% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Tirzepatide

    Retalux · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.91% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Tirzepatide

    Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.7% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Tirzepatide

    Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.96% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Tirzepatide

    Retalux · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Tirzepatide

    Retalux · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Tirzepatide

    Retalux · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.9% purity · Doc 92

    Document structure and test panels align with what we expect from authentic lab reports.

    Consistent with a legitimate COA71Solid
  • Tirzepatide

    Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.8% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Tirzepatide

    Retalux · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Tirzepatide

    Retalux · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Tirzepatide

    Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.366% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • Tirzepatide

    Hang Sciences · Sep 5, 2026 · Core panels 67% · 2/7 panels · 96.89% purity

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns68Doc score
  • Tirzepatide

    HelixBridge · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.09% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns68Mixed signals
  • Tirzepatide

    Pepturion · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.87% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns63Mixed signals
  • Tirzepatide

    Pepturion · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns63Mixed signals
  • Tirzepatide

    Pepturion · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.8% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns63Mixed signals
  • Tirzepatide

    Pepturion · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns63Mixed signals
  • Tirzepatide

    Lumira · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns58Mixed signals
  • Tirzepatide

    Lumira · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns58Mixed signals
  • Tirzepatide

    Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.7% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns58Mixed signals
  • Tirzepatide

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.75% purity · Doc 62

    Missing panels or key metadata — not enough evidence to treat this as a full certificate.

    Incomplete documentation47Concerning
  • Tirzepatide

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.867% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns47Concerning
  • Tirzepatide

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.664% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns47Concerning
  • TIRZEPATIDE

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.849% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns47Concerning
  • Tirzepatide

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.863% purity · Doc 62

    Missing panels or key metadata — not enough evidence to treat this as a full certificate.

    Incomplete documentation47Concerning
  • TIRZEPATIDE

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.46% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns47Concerning
  • TIRZEPATIDE

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.704% purity · Doc 62

    Missing panels or key metadata — not enough evidence to treat this as a full certificate.

    Incomplete documentation47Concerning
  • TIRZEPATIDE

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.731% purity · Doc 62

    Missing panels or key metadata — not enough evidence to treat this as a full certificate.

    Incomplete documentation47Concerning
  • TIRZEPATIDE

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.39% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns47Concerning
  • TIRZEPATIDE

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.768% purity · Doc 62

    Missing panels or key metadata — not enough evidence to treat this as a full certificate.

    Incomplete documentation47Concerning
  • TIRZEPATIDE

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.67% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns47Concerning
  • TIRZEPATIDE

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.8% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns47Concerning
  • TIRZEPATIDE

    Paramount Peptides · Sep 5, 2026 · Core panels 33% · 1/7 panels · 99.543% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns47Concerning
  • Tirzepatide

    Brand not listed · Jul 28, 2026 · Core panels 100% · 4/7 panels · 99.9% purity

    Multiple signals on this document conflict with known lab formats or verification patterns.

    Evidence suggests fabrication25Doc score

Community-sourced

Help build the COA record

PeptIQ’s market snapshot comes from moderator-approved certificates and curated peptide brands and testing laboratories — not invented stats. Contribute a COA or claim your listing.

Community submissions are reviewed before they appear on public market pages. Private COA scans stay private until you share them.

Brand owners: claim or list your peptide brand, upload COAs tied to it in the app, then track trust scores on your public brand page and the COA market.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.